Close this search box.
Close this search box.

March 7, 2022

Within3 in EPM: How virtual engagement will transform pharma

Within the broader context of insights management, virtual engagement will continue to change how life science organizations work.
virtual engagement and insights management

Within3 VP of Medical Affairs Mike Abbadessa writes in the January-February 2022 issue of European Pharmaceutical Manufacturer about how virtual engagement will continue to drive results, gain insights, and equip teams for our post-COVID reality. Abbadessa calls out three areas where virtual engagement and insights management will have the most impact:

The return of in-person events – with a virtual twist

As the life science industry addresses COVID-related challenges to in-person events – including disease variants and outbreaks, changing travel preferences, and the rise of remote work and telehealth – both large-scale events like medical congresses and smaller gatherings like advisory boards will increasingly feature more virtual elements.

Medical conferences will retain the critical in-person networking and scientific exchange, but planning and execution will be more efficient with an assist from asynchronous collaboration before and during the event. And as medical affairs teams, in particular, continue to find value in engaging global experts through more frequent virtual touchpoints, online interactions will become a key business strategy.

Improvements in trial diversity

Because virtual interaction allows patient engagement to happen when and wherever it is most convenient for them, more patients can participate in the development of trial protocols, remote monitoring, and other aspects of the clinical trial experience. When logistical barriers are lowered and patients prioritized, clinical trial enrollment is more successful.

Insights as a strategic priority

Pharmaceutical teams are gathering insights from multiple channels – 1:1 conversations, medical congresses, advisory boards, and patient engagement, to name just a few. As these multiple streams create a huge volume of data that’s time-consuming to parse, most organizations will recognize the need for a holistic approach to insights management throughout the year and across the product development process. By unifying these disparate activities, teams can eliminate silos and increase their precision and speed in developing life-changing therapies.

Read the article.

Related Posts:

virtual engagement for medical affairs

Within3 in MedCityNews: Digital collaboration here to stay for Pfizer, Merck, others

medical affairs and digital influencers

Within3 in Journal of mHealth: Medical Affairs Should Work with Digital Influencers

diversity in life science

Within3 in

More insights, direct to your inbox.